Old Web
English
Sign In
Acemap
>
authorDetail
>
Roberto A. Salas Fragomeni
Roberto A. Salas Fragomeni
Harvard University
Melanoma
Apoptosis
Cancer research
Immunology
Biology
6
Papers
87
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics
2014
PLOS ONE
Dennie T. Frederick
Roberto A. Salas Fragomeni
Aislyn P. Schalck
Isabel Ferreiro-Neira
Taylor Hoff
Zachary A. Cooper
Rizwan Haq
David J. Panka
Lawrence N. Kwong
Michael A. Davies
James C. Cusack
Keith T. Flaherty
David E. Fisher
James W. Mier
Jennifer A. Wargo
Ryan J. Sullivan
Show All
Source
Cite
Save
Citations (36)
Use of selective inhibition of nuclear export (SINE) using a CRM1/XPO1 antagonist to overcome resistance to CPT-11 in colon cancer in preclinical models.
2013
Journal of Clinical Oncology
Hye Won Chung
Roberto A. Salas Fragomeni
Sharon Shacham
Michael Kauffman
James C. Cusack
Show All
Source
Cite
Save
Citations (1)
CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
2013
Molecular Cancer Therapeutics
Roberto A. Salas Fragomeni
Hye Won Chung
Yosef Landesman
William Senapedis
Jean-Richard Saint-Martin
Hensin Tsao
Keith T. Flaherty
Sharon Shacham
Michael Kauffman
James C. Cusack
Show All
Source
Cite
Save
Citations (48)
1